All data are based on the daily closing price as of November 11, 2026
t

Towa Pharmaceutical

4553.TSE
21.78 USD
-0.39
-1.76%

Overview

Last close
21.78 usd
Market cap
1.07B usd
52 week high
28.23 usd
52 week low
16.83 usd
Target price
33.68 usd

Valuation

P/E
20.8705
Forward P/E
16.7785
Price/Sales
0.6164
Price/Book Value
0.9105
Enterprise Value
2.23B usd
EV/Revenue
1.264
EV/EBITDA
18.1485

Key financials

Revenue TTM
1.76B usd
Gross Profit TTM
639.06M usd
EBITDA TTM
296.25M usd
Earnings per Share
1.06 usd
Dividend
0.5 usd
Total assets
2.96B usd
Net debt
1.15B usd

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.
  • Symbol
    4553.TSE
  • Exchange
    TSE
  • Isin
    JP3623150004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Kadoma
  • Web site
    https://www.towayakuhin.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top